These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37733157)

  • 1. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
    Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
    Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
    Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
    Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
    Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
    Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the detectability of UBOs in Neurofibromatosis Type I patients with proton density-weighted and FLAIR sequences in 3T MRI.
    Tritt S; Hillenbrand N; Liesirova K; Moein G; Kieslich M; Porto L
    Eur J Paediatr Neurol; 2018 Jul; 22(4):615-619. PubMed ID: 29610060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
    DeBella K; Poskitt K; Szudek J; Friedman JM
    Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
    Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
    Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.
    Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globus pallidus high-signal lesions: A predominant MRI finding in children with neurofibromatosis type 1.
    Khan A; Beri S; Baheerathan A; Balki A; Hussain N; Gosalakkal J
    Ann Indian Acad Neurol; 2013 Jan; 16(1):53-6. PubMed ID: 23661963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
    Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
    Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
    Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
    Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
    Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.
    Billiet T; Mädler B; D'Arco F; Peeters R; Deprez S; Plasschaert E; Leemans A; Zhang H; den Bergh BV; Vandenbulcke M; Legius E; Sunaert S; Emsell L
    Neuroimage Clin; 2014; 4():649-58. PubMed ID: 24936416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.
    Tognini G; Ferrozzi F; Garlaschi G; Piazza P; Patti A; Virdis R; Bertolino C; Bertolino G; Manfredini D; Zompatori M; Crisi G
    J Comput Assist Tomogr; 2005; 29(3):298-304. PubMed ID: 15891494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
    Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
    Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.
    Eby NS; Griffith JL; Gutmann DH; Morris SM
    Dev Med Child Neurol; 2019 Aug; 61(8):972-978. PubMed ID: 30659594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1.
    Jandhyala NR; Garcia MR; Kim M; Yohay K; Segal D
    Pediatr Neurol; 2024 Jul; 156():66-71. PubMed ID: 38733856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
    Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
    Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unidentified bright objects and neuropsychiatric disturbances].
    Bassi B; Vannelli S; Giraudo MC; Burdino E; Rigardetto R
    Minerva Pediatr; 2013 Aug; 65(4):371-81. PubMed ID: 24051970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.
    Ferraz-Filho JR; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Pediatr Radiol; 2012 Apr; 42(4):449-54. PubMed ID: 22033857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
    Tan RM; Chng SM; Seow WT; Wong J; Lim CC
    Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.